
Precision. Performance. Profitability.
The ZEISS Advantage
Strategic focus

ZEISS strategically prioritizes surgical areas demonstrating sustained long-term growth potential, driven by stable, low-risk market dynamics influenced by aging populations and other global megatrends. Underscoring its commitment to leading innovation in these fields, ZEISS significantly invests in research and development – dedicating 15% of its revenue.1 This substantial, ongoing investment fuels the development of cutting-edge technologies across its portfolio, with a particular intensity within its Medical Technology segment, ensuring ZEISS remains at the forefront of surgical advancement.2
This dedicated focus and investment are clearly directed towards complex and growing surgical disciplines highly relevant to specialized care, including Otolaryngology (ENT), Plastic & Reconstructive Surgery (P&R), and Neurosurgery. These fields often involve intricate anatomy, require microsurgical precision, and address increasingly prevalent conditions or demands for advanced interventions. Across these specialties, ZEISS integrates digital solutions for data management, workflow optimization, and remote collaboration.
Consequently, ZEISS offers solutions born from this focused innovation directly benefiting Ambulatory Surgery Centers specializing in these key, high-growth surgical categories. Advancements in visualization, minimally invasive techniques, workflow efficiency, and digital connectivity—all fueled by ZEISS's significant R&D investment—enable more complex procedures to be performed safely and effectively in the ASC setting. This presents ASCs with clear opportunities to expand their procedural scope, increase case volume, attract top surgical talent, enhance patient outcomes, and ultimately achieve a significant return on their investment by leveraging ZEISS's state-of-the-art, specialized technology platforms.
R&D investments in key areas of market growth
Source: Precedence Research, Prophecy Market Insights
Return on investment

Boost your business performance with ZEISS ASC Solutions. ZEISS’ legendary optics, pioneering technological advancements and integrated digital platforms converge to streamline your surgical workflows and maximize operational efficiency.
Reduced surgical time
ZEISS visualization systems allow surgeons to identify anatomical structures with greater clarity and precision, enabling them to perform procedures more efficiently. Shorter surgical times translate to higher patient throughput, maximizing the utilization of operating rooms and staff.
Efficient OR turnover
Surgical equipment setup is an area where turnover delays commonly occur. ZEISS surgical microscopes are designed to make OR turnover more efficient, with intuitive interfaces and automated features to improve usability and reduce common causes of delay.
Increased productivity
The superior ergonomics of ZEISS surgical microscopes reduce surgeon fatigue, allowing for longer and more focused procedures, potentially increasing the number of cases that can be performed in a day.
Cost of ownership as a % of OR revenue
Neurological Suite |
|
---|---|
Craniotomy per day |
2 |
Average revenue |
$65,000 |
Revenue per day |
$130,000 |
Surgery days per week |
3 |
Weeks per year |
52 |
Annual suite revenue |
$20,280,000 |
|
|
Microscope cost |
$750,000 |
Service (4 years) |
$160,000 |
Total cost (5 years) |
$910,000 |
Residual value (15%) |
$112,500 |
Net cost |
$797,500 |
Net cost per year |
$159,500 |
|
|
Microscope as a % of annual revenue |
0.79% |
Patient safety

The average cost of an SSI (surgical site infection) incident ranges from $11,874 - $34,670.3
While improving intra-operative efficiency is important for a number of reasons, chief among them is the impact on patient safety. Prolonged procedure duration is associated with several negative clinical outcomes, including increased risk of SSI, as well as pulmonary complications.
A meta-analysis of 81 studies found that the likelihood of SSI increased with increasing time increments; for example, a 13%, 17%, and 37% increased likelihood for every 15 min, 30 min, and 60 min of surgery, respectively.4
ZEISS surgical microscopes support disinfection success even in the time-sensitive environment of the OR. Reduced cabling and intelligent design enable simple, quick, and effective cleaning, and help prevent microbial contamination of your surgical visualization system — and your patients.
Unlike other traditional surgical microscopes, ZEISS microscopes allow the option to use LED surgical lights, rather than Xenon bulbs. Xenon bulbs burn brighter and hotter than LED lights, posing particular safety risks for pediatric patients. Clinical studies have documented how the most common complication is auricular burns and scarring during otologic surgeries. Furthermore, these studies conclude 300W Xenon bulbs are responsible for these injuries.5,6,7
Talent attraction & retention

According to the PwC, 82% of healthcare executives say difficulty attracting and retaining talent is a serious business risk.8 Physician shortages persist and there remain more open positions than physicians to fill them. 6.5M+ healthcare professionals will permanently leave by 2026, and only 1.9M will replace them.9 There is a projected average of 24,000+ openings for physicians and surgeons each year over the next decade.10
ZEISS’ cutting-edge visualization systems empower surgeons to perform complex procedures with heightened accuracy and confidence. This translates directly into enhanced surgical outcomes, reduced risk of complications and improved patient care. To attract elite surgical talent, equipping your ASC with ZEISS signals a commitment to providing the very best tools available.
Beyond superior performance, ZEISS surgical equipment features ergonomic designs that enhance surgeon comfort during procedures, which is vital in the high-volume environment of ASCs. Intuitive controls reduce fatigue and improve workflow, supporting long-term surgeon wellbeing — a critical factor in retention. ZEISS’ robust digital platforms offer new ways of peer collaboration and knowledge-sharing, enriching surgeon experience and satisfaction.
Partnering with ZEISS not only elevates your ASC’s surgical capabilities but also enhances its reputation as a high-caliber institution dedicated to quality, innovation and supporting its valued surgical teams.
Outfit your OR with ease!
We have everything you need to outfit your OR easily and cost-efficiently. Access our resources and offerings by selecting below:
-
1
Carl Zeiss AG. (2024). Facts & Figures. ZEISS Group. https://www.zeiss.com/corporate/en/about-zeiss/present/facts-figures.html
-
2
Carl Zeiss AG. (2024, December 17). Good overall result and revenue growth for the ZEISS Group. Via Ritzau. https://via.ritzau.dk/pressemeddelelse/14192699/good-overall-result-and-revenue-growth-for-the-zeiss-group?publisherId=13560077&lang=en
-
3
Scott, R. D., II. (2009). The direct medical costs of HAIs in U.S. hospitals and the benefits of prevention. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/153993
-
4
Cheng, Chen, et al. (2017). Prolonged operative duration increases risk of surgical site infections: A systematic review. Surgical Infections, 18(6), 722–735. https://pubmed.ncbi.nlm.nih.gov/28832271
-
5
Parodi, Marine. et al. (2015). Using a new otologic operating microscope: Unexpected complications. International Journal of Pediatric Otorhinolaryngology, 79(11), 1823–1826.
-
6
Batesa, James, et al. (2018). Otological surgery in pediatric photosensitive patients. International Journal of Pediatric Otorhinolaryngology, 113, 100–102.
-
7
Imbery, T. Edward, MD, et al. (2017). Thermal variations of operative microscopes in otology. Otolaryngology–Head and Neck Surgery, 157(5), 849–852.
-
8
U.S. Bureau of Labor Statistics. (n.d.). Occupational Outlook Handbook: Physicians and surgeons. https://www.bls.gov/ooh/healthcare/physicians-and-surgeons.html
-
9
Payerchin, Richard. (2023, October 6). National jobless rate holds at 3.8% for September. Medical Economics. https://www.medicaleconomics.com/view/national-jobless-rate-holds-at-3-8-for-september
-
10
Robeznieks, Andis. (2022, April 13). Doctor shortages are here – and they’ll get worse if we don’t act fast. https://www.ama-assn.org/practice-management/sustainability/doctor-shortages-are-here-and-they-ll-get-worse-if-we-don-t-act